As of Dec 08
| -0.62 / -24.75%|
The 3 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +426.32% increase from the last price of 1.90.
The current consensus among 3 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.